Biopharma Stock Alert for La Jolla Pharmaceuticals Co. Issued by StockPreacher

Biopharma Stock Alert for La Jolla Pharmaceuticals Co. Issued by StockPreacher  DALLAS, March 5, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring La Jolla Pharmaceuticals Co. (Pink Sheets:LJPC). The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.  The full report is available at: http://www.stockpreacher.com/n/LJPC  Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/StockPreacher  La Jolla Pharmaceutical Co. (LJPC) is a biopharmaceutical company focused on the development and testing of Riquent® as a treatment for Lupus nephritis. Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues. The Company's wholly owned subsidiary is La Jolla Ltd.  Message Board Search for LJPC: http://www.boardcentral.com/boards/LJPC  In the report, the analyst notes:  "The Company has discontinued its clinical trials for Riquent and has discontinued all research, development and clinical activities. In addition, the Company has terminated substantially its entire workforce. Accordingly, the Company's operating expenses and net loss for the three and nine months ended September30, 2009, are expected to be substantially lower than reported for the three and nine months ended September30, 2008.  "LJPC said this week its stock will be delisted from the Nasdaq on Thursday March 4th, and added that shareholders did not respond to its plans to merge with another drug company. The stock will be suspended from the Nasdaq starting Thursday morning after a panel denied LJPC's request for an extension. The Company does not have any products on the market, and trials of the only drug it was developing, the lupus treatment Riquent, were suspended more than a year ago. The Company proposed a merger with Adamis Pharmaceuticals Corp., but it did not receive enough responses from shareholders to hold a meeting."  To read the entire report visit: http://www.stockpreacher.com/n/LJPC  See what investors are saying about LJPC at penny stock forum  StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com  StockPreacher.com Disclosure  StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly owned by BlueWave Advisors, LLC. StockPreacher.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.  CONTACT:  StockPreacher.com           Nic Lesmeister           (469)-252-3505           info@stockpreacher.com